Sunflower Pharmaceutical Group Co.,Ltd
Sunflower Pharmaceutical Group Co., Ltd., a prominent player in the pharmaceutical industry, is headquartered in China (CN) and operates extensively across various regions. Founded in 2001, the company has established itself as a leader in the development and manufacturing of high-quality pharmaceutical products, including innovative generics and specialty medications. With a commitment to research and development, Sunflower Pharmaceutical Group focuses on areas such as oncology, cardiology, and neurology, offering unique formulations that cater to diverse patient needs. The company’s dedication to quality and compliance has earned it a strong market position, recognised for its contributions to healthcare advancements. Through strategic partnerships and a robust distribution network, Sunflower continues to expand its reach, making significant strides in improving global health outcomes.
DitchCarbon Score
How does Sunflower Pharmaceutical Group Co.,Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sunflower Pharmaceutical Group Co.,Ltd's score of 10 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sunflower Pharmaceutical Group Co.,Ltd's reported carbon emissions
Sunflower Pharmaceutical Group Co., Ltd, headquartered in CN, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical sector are increasingly focusing on sustainability and climate commitments, often aiming to align with global standards such as the Science Based Targets initiative (SBTi). As the industry evolves, it is anticipated that Sunflower Pharmaceutical Group will adopt similar practices to enhance its environmental responsibility and address climate change effectively.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sunflower Pharmaceutical Group Co.,Ltd is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
